Latest immunotherapy news
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
posted August 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rituximab Not Superior to Conventional Strategy for Eosinophilic Granulomatosis With Polyangiitis
posted August 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Healthy Lifestyle in Early Childhood Linked to Lower Risk for IBD 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Bowel Urgency in Ulcerative Colitis Linked to Disease-Related Disability Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
